Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 833-842

  Adriani, Walter ^a   Travaglini, Domenica ^a   Lacivita, Enza ^b   Saso, Luciano ^c   Leopoldo, Marcello ^b   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Animal Model; Anxiety; Locomotion; LP 211; Novelty seeking; Phase shift

Indexed keywords

LP 211; LP 378; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APTITUDE TEST; ARTICLE; AVERSIVE BEHAVIOR; BRAIN DEPTH STIMULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMOTION; EXPLORATORY BEHAVIOR; HABITUATION; LOCOMOTION; MALE; MOTIVATION; MOUSE; NEUROMODULATION; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; EMOTIONS; MALE; MICE; MOTIVATION; MOTOR ACTIVITY; PIPERAZINES; RECEPTORS, SEROTONIN; SEROTONIN RECEPTOR AGONISTS;

EID: 84855958018     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.09.012     Document Type: Article

References (77)

1. H. Abdi, and L.J. Williams Honestly significant difference (HSD) test N.J. Salkind, D.M. Dougherty, B. Frey, Encyclopedia of Research Design 2010 Sage Thousand Oaks, CA, USA 583 585
2. W. Adriani, O. Granstrem, E. Romano, S. Koroleva, and G. Laviola Modulatory effects of Cortexin and Cortagen on locomotor activity and anxiety-related behavior in mice Open Neuro-Psycho-Pharmacol. J. 2009 2/1/22
3. M.C. Antle, M.D. Ogilvie, G.E. Pickard, and R.E. Mistlberger Response of the mouse circadian system to serotonin 1A/2/7 agonists in vivo: surprisingly little J. Biol. Rhythms 18 2003 145 148
4. S.J. Ballaz, H. Akil, and S.J. Watson Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior Neuroscience 147 2007 428 438
5. J. Bockaert, S. Claeysen, C. Bécamel, A. Dumuis, and P. Marin Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation Cell. Tissue Res. 326 2006 553 572
6. D.B. Boivin, C.A. Czeisler, D.J. Dijk, J.F. Duffy, S. Folkard, D.S. Minors, P. Totterdell, and J.M. Waterhouse Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects Arch. Gen. Psychiatry 54 1997 145 152
7. P. Bonaventure, L. Kelly, L. Aluisio, J. Shelton, B. Lord, R. Galici, K. Miller, J. Atack, T.W. Lovenberg, and C. Dugovic Selective blockade of 5-hydroxy-tryptamine (5-HT) 7 receptors enhances 5-HT transmission, antidepressant-like behaviour, and rapid eye movement sleep suppression induced by citalopram in rodents J. Pharmacol. Exp. Ther. 321 2007 690 698
8. N. Brunello, R. Armitage, I. Feinberg, E. Holsboer-Trachsler, D. Leger, P. Linkowski, W.B. Mendelson, G. Racagni, B. Saletu, A.L. Sharpley, F. Turek, E. Van Cauter, and J. Mendlewicz Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment Neuropsycho-biology 42 2000 107 119
9. S. Cabib, S. Puglisi-Allegra, C. Genua, H. Simon, M. Moal, and P.V. Piazza Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus Psychopharmacology 125 1996 92 96
10. R. Canese, E.M. Marco, F. De Pasquale, F. Podo, G. Laviola, and W. Adriani Differential response to serotonergic drugs in rat forebrains: a phMRI study NeuroImage 58 2011 885 994
11. A. Cifariello, A. Pompili, and A. Gasbarri 5-HT7 receptors in the modulation of cognitive processes Behav. Brain Res. 195 2008 171 179
12. D. Conversi, A. Bonito-Oliva, C. Orsini, and S. Cabib Genetic liability increases propensity to prime-induced reinstatement of conditioned place preference in mice exposed to low cocaine Psychopharmacology 198 2008 287 296
13. V.S. Costa, P. Duchatelle, M. Boulouard, and F. Dauphin Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age related deficits in spatial recognition memory in the mouse Neuropsycho-pharmacology 34 2009 488 500
14. R.A. Cutrera, M. Saboureau, and P. Pévet Phase-shifting effect of 8-OH-DPAT, a 5-HT1A/5-HT7 receptor agonist, on locomotor activity in golden hamster in constant darkness Neurosci. Lett. 210 1996 1 4
15. T.E. Dudley, L.A. Di Nardo, and J.D. Glass Endogenous regulation of serotonin release in the hamster supra-chiasmatic nucleus J. Neurosci. 18 1998 5045 5552
16. M.J. Duncan, K.E. Grear, and M.A. Hoskins Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus Brain Res. 1008 2004 40 48
17. M.J. Duncan, S. Temel, and L. Jennes Localisation of serotonin 5-HT7 receptor immunoreactivity in the rat brain Soc. Neurosci. Abs. Poster 2001 380 418
18. J.C. Ehlen, G.H. Grossman, and J.D. Glass In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the supra-chiasmatic nucleus J. Neurosci. 21 2001 5351 5357
19. M. Gardani, and S.M. Biello The effects of photic and non photic stimuli in the 5-HT7 receptor knockout mouse Neuroscience 152 2008 245 253
20. J.D. Glass, G.H. Grossman, L. Farnbauch, and L. Di Nardo Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus J. Neurosci. 23 2003 7451 7460
21. M. Guscott, L.J. Bristow, K. Hadingham, T.W. Rosahl, M.S. Beer, J.A. Stanton, F. Bromidge, A.P. Owens, I. Huscroft, J. Myers, N.M. Rupniak, S. Patel, P.J. Whiting, P.H. Hutson, K.C. Fone, S.M. Biello, J.J. Kulagowski, and G. McAllister Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression Neuropharmacology 48 2005 492 502
22. J.J. Hagan, G.W. Price, P. Jeffrey, N.J. Deeks, T. Stean, D. Piper, M.I. Smith, N. Upton, A.D. Medhurst, D.N. Middlemiss, G.J. Riley, P.J. Lovell, S.M. Bromidge, and D.R. Thomas Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist Br. J. Pharmacol. 130 2000 539 548
23. P.B. Hedlund The 5-HT7 receptor and disorders of the nervous system: an overview Psychopharmacology 206 2009 345 354
24. P.B. Hedlund, S. Huitron-Resendiz, S.J. Henriksen, and J.G. Sutcliffe 5-HT7 receptor inhibition and inactivation induce antidepressant-like behavior and sleep pattern Biol. Psychiatry 58 2005 831 837
25. P.B. Hedlund, M. Leopoldo, S. Caccia, G. Sarkisyan, C. Fracasso, G. Martelli, E. Lacivita, F. Berardi, and R. Perrone LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor Neurosci. Lett. 481 2010 12 16
26. P.B. Hedlund, and J.G. Sutcliffe Functional, molecular and pharmacological advances in 5-HT7 receptor research Trends Pharmacol. Sci. 25 2004 481 486
27. P.B. Hedlund, and J.G. Sutcliffe 5-HT7 receptors as favorable pharmacological targets for drug discovery B.L. Roth, The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics 2006 Humana Press Totowa, NJ, USA 517 535
28. S. Hjorth, A. Carlsson, P. Lindberg, D. Sanchez, H. Wikström, L.E. Arvidsson, U. Hacksell, and J.L.G. Nilsson 8-Hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity J. Neural Transm. 55 1982 169 188
29. Y. Horinouchi, J. Akiyoshi, A. Nagata, H. Matsushita, T. Tsutsumi, K. Isogawa, T. Noda, and H. Nagayama Reduced anxious behavior in mice lacking the CCK2 receptor gene Eur. Neuropsychopharmacol. 14 2004 157 161
30. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, and P.P. Humphrey International Union of Pharmacology classification of receptors for 5-hydroxy-tryptamine (Serotonin) Pharmacol. Rev. 46 1994 157 203
31. D. Hoyer, J.P. Hannon, and G.R. Martin Molecular, pharmacological and functional diversity of 5-HT receptors Pharmacol. Biochem. Behav. 71 2002 533 554
32. L.M. Jordan, J. Liu, P.B. Hedlund, T. Akay, and K.G. Pearson Descending command systems for the initiation of locomotion in mammals Brain Res. Rev. 57 2008 183 191
33. C. Kikuchi, H. Nagaso, T. Hiranuma, and M. Koyama Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor J. Med. Chem. 42 1999 533 535
34. E. Kvachnina, G. Liu, A. Dityatev, U. Renner, A. Dumuis, D.W. Richter, G. Dityateva, M. Schachner, T.A. Voyno-Yasenetskaya, and E.G. Ponimaskin 5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology J. Neurosci. 25 2005 7821 7830
35. E.S. Landry, N.P. Lapointe, C. Rouillard, D. Levesque, P.B. Hedlund, and P.A. Guertin Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice Eur. J. Neurosci. 24 2006 535 546
36. G. Laviola, G. Dell'Omo, E. Alleva, and G. Bignami Ontogeny of cocaine hyperactivity and conditioned place preference in mice Psychopharmacology 107 1992 221 228
37. G. Laviola, S. Macri, S. Morley-Fletcher, and W. Adriani Risk-taking behaviour in adolescent mice: psycho-biological determinants and early epigenetic influence Neurosci. Biobehav. Rev. 27 2003 19 31
38. M. Leopoldo, F. Berardi, N.A. Colabufo, M. Contino, E. Lacivita, M. Niso, R. Perrone, and V. Tortorella Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazine-alkylamides, a new class of 5-hydroxy-tryptamine7 receptor agents Med. Chem. 47 2004 6616 6624
39. M. Leopoldo, E. Lacivita, F. Berardi, R. Perrone, and P.B. Hedlund Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders Pharmacol. Ther. 129 2011 120 148
40. M. Leopoldo, E. Lacivita, P. De Giorgio, C. Fracasso, S. Guzzetti, S. Caccia, M. Contino, N. Colabufo, F. Berardi, and R. Perrone Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazine- hexanamides: influence on lipophilicity and 5-HT7 receptor activity; Part III J. Med. Chem. 51 2008 5813 5822
41. X.M. Li, J. Beau, P. Delagrange, E. Mocaer, and F. Lévi Circadian rhythm entrainment with melatonin, melatonin receptor antagonist S22153 or their combination in mice exposed to constant light J. Pineal Res. 37 2004 176 184
42. T.W. Lovenberg, B.M. Baron, L. de Lecea, J.D. Miller, R.A. Prosser, M.A. Rea, P.E. Foye, M. Racke, A.L. Slone, B.W. Siegel, P.E. Danielson, J.G. Sutcliffe, and M.G. Erlander A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms Neuron 11 1993 449 458
43. M.X. Ma, Y.M. Chen, J. He, T. Zeng, and J.H. Wang Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice Neuroscience 47 2007 1059 1065
44. M.A. Madriaga, L.C. McPhee, T. Chersa, K.J. Christie, and P.J. Whelan Modulation of locomotor activity by multiple 5-HT and DA receptor subtypes in the neonatal mouse spinal cord J. Neurophysiol. 92 2004 1566 1576
45. J. Menard, and D. Treit Effects of centrally administered anxiolytic compounds in animal models of anxiety Neurosci. Biobehav. Rev. 23 1999 591 613
46. A. Meneses 5-HT system and cognition Neurosci. Biobehav. Rev. 23 1999 1111 1125
47. A. Meneses Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian / instrumental learning task Behav. Brain Res. 155 2004 275 282
48. A. Meneses A pharmacological analysis of an associative learning task: function of 5-HT1 to 5-HT7 receptor subtypes on a Pavlovian/instrumental autoshaped memory Learn. Mem. 10 2003 363 372
49. T. Meuser, C. Pietruck, A. Gabriel, G.X. Xie, K.J. Lim, and P. Palmer 5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons Life Sci. 71 2002 2279 2289
50. O. Mnie-Filali, C. Faure, L. Lambás-Señas, M. El Mansari, H. Belblidia, E. Gondard, A. Etiévant, H. Scarna, A. Didier, A. Berod, P. Blier, and N. Haddjeri Pharmacological blockade of 5-HT7 receptors as a putative fast acting anti-depressant strategy Neuropsycho-pharmacology 36 2011 1275 1288
51. O. Mnie-Filali, L. Lambás-Señas, L. Zimmer, and N. Haddjeri 5-HT7 receptor antagonists as a new class of anti-depressants Drug News Perspect. 20 2007 613 618
52. J.M. Monti, M. Leopoldo, and H. Jantos The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat Behav. Brain Res. 191 2008 184 189
53. L.S. Nandam, D. Jhaveri, and P. Bartlett 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression Clin. Exp. Pharmacol. Physiol. 34 2007 546 551
54. C. Orsini, A. Bonito-Oliva, D. Conversi, and S. Cabib Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains Psychopharmacology 181 2005 327 336
55. M.G. Packard, and J.L. McGaugh Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning Neurobiol. Learn. Mem. 1 1996 65 72
56. G. Perez-Garca, and A. Meneses Ex-vivo study of 5-HT1A and 5-HT7 receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia Behav. Brain Res. 195 2008 139 146
57. G. Perez-Garca, and A. Meneses Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task Behav. Brain Res. 163 2005 136 140
58. G.E. Pickard, and M.A. Rea Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms Biol. Cell 89 1997 513 523
59. R.A. Prosser Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro Brain Res. 808 1998 31 41
60. A.J. Roberts, T. Krucker, C.L. Levy, K.A. Slanina, J.G. Sutcliffe, and P.B. Hedlund Mice lacking 5-HT7 receptors show specific impairments in contextual learning Eur. J. Neurosci. 19 2004 1913 1922
61. C. Roberts, C.J. Langmead, E.M. Soffin, C.H. Davies, L. Lacroix, and C.A. Heidbreder The effect of SB-269970-A, a 5-HT7 receptor antagonist, on 5-HT release and cell firing W.T. O'Connor, J.P. Lowry, J.J. O'Connor, R.D. O'Neill, Monitoring Molecules in Neuroscience 2001 University College Dublin, Ireland 348 350
62. B. Rusak, and I. Zucker Neural regulation of circadian rhythms Physiol. Rev. 59 1979 449 526
63. G. Sarkisyan, and P.B. Hedlund The 5-HT7 receptor is involved in allocentric spatial memory information processing Behav. Brain Res. 202 2009 26 31
64. G. Sarkisyan, A.J. Roberts, and P.B. Hedlund The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior Behav. Brain Res. 209 2010 99 108
65. Z. Sarnyai, E.L. Sibille, C. Pavlides, R.J. Fenster, B.S. McEwen, and M. Toth Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors Proc. Natl. Acad. Sci. USA 97 2000 14731 14736
66. S. Schuhler, B. Pitrosky, M. Saboureau, N. Lakhdar-Ghazal, and P. Pévet Role of the thalamic intergeniculate leaflet and its 5-HT afferences in the chronobiological properties of 8-OH-DPAT and triazolam in syrian hamster Brain Res. 849 1999 16 24
67. T. Sharp, R. Mcquade, S. Bramwell, and S. Hjorth Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo Naunyn-Schmiedebergs Arch. Pharmacol. 348 1993 339 346
68. J. Sprouse, L. Reynolds, X. Li, J. Braselton, and A. Schmidt 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production Neuropharmacology 46 2004 52 62
69. T. Strachan, G. Ferrara, and B.L. Roth Screening the receptorome: an efficient approach for drug discovery and target validation Drug Discov. Today 11 2006 708 716
70. D.R. Thomas, and J.J. Hagan 5-HT7 receptors Curr. Drug Targets CNS Neurol. Disord. 3 2004 81 90
71. D.R. Thomas, S. Melotto, M. Massagrande, A.D. Gribble, P. Jeffrey, A.J. Stevens, N.J. Deeks, P.J. Eddershaw, S.H. Fenwick, G. Riley, T. Stean, C.M. Scott, M.J. Hill, D.N. Middlemiss, J.J. Hagan, G.W. Price, and I.T. Forbes SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats Br. J. Pharmacol. 139 2003 705 714
72. A. Wesolowska, A. Nikiforuk, and K. Stachowicz Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB-269970 after intra-hippocampal administration to rats Eur. J. Pharmacol. 553 2006 185 190
73. A. Wesolowska, A. Nikiforuk, K. Stachowicz, and E. Tatarczynska Effect of the selective 5-HT7 receptor antagonist SB-269970 in animal models of anxiety and depression Neuropharmacology 51 2006 578 586
74. A. Wesolowska, E. Tatarczynska, A. Nikiforuk, and E. Chojnacka-Wojcik Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice Eur. J. Pharmacol. 555 2007 43 47
75. M.L. Woolley, C.A. Marsden, and K.C.F. Fone 5-HT6 receptors Curr. Drug Targets CNS Neurol. Dis. 3 2004 81 90
76. J.L.W. Yau, J. Noble, and J.R. Seckl Acute restraint stress increases 5-HT7 receptor mRNA expression in rat hippocampus Neurosci. Lett. 309 2001 141 144
77. J. Zhang, J. He, Y.M. Chen, J.H. Wang, and Y.Y. Ma Morphine and propranolol co-administration impair consolidation of Y-maze spatial recognition memory Brain Res. 1230 2008 150 157